Yuying He

Title: Yuying He: Innovator in Intestinal Cancer Research

Introduction

Yuying He is a prominent inventor based in Anhui, China. She has made significant contributions to the field of cancer research, particularly focusing on intestinal cancer. Her innovative work has led to advancements in the culture methods for primary cells, which are crucial for understanding and treating this disease.

Latest Patents

Yuying He holds a patent for a culture medium and culture method for primary cells of intestinal cancer. This patent discloses a culture medium that includes an initial culture medium, a Rho protease inhibitor, an antibiotic, gastrin, A8301, a non-essential amino acid, cholera toxin, an insulin-like growth factor-1, nicotinamide, insulin, fetal bovine serum, and an additive selected from at least one of a B27 additive and an N2 additive. The use of this culture medium allows for effective and rapid expansion of primary cells of intestinal cancer. The expanded cells maintain the pathological characteristics of patients, improving the culture success rate and cell expansion rate, which provides a research foundation for personalized treatment of patients.

Career Highlights

Yuying He is currently associated with Precedo Pharmaceuticals Co., Ltd., where she continues her research and development efforts. Her work has been instrumental in enhancing the understanding of intestinal cancer and developing methods that can lead to better treatment options.

Collaborations

Yuying has collaborated with notable colleagues, including Qingsong Liu and Cheng Chen. These collaborations have further enriched her research and contributed to the advancements in cancer treatment methodologies.

Conclusion

Yuying He is a dedicated inventor whose work in developing a culture medium for intestinal cancer cells has the potential to revolutionize personalized treatment approaches. Her contributions to cancer research are invaluable and highlight the importance of innovation in medical science.